In Brief: IPI Medical
This article was originally published in The Gray Sheet
Executive Summary
IPI Medical: House Commerce/Oversight and Investigations Subcommittee Chair Joe Barton (R-Tex.) holds teleconference with FDA officials on March 6 to discuss an April 1995 consent decree between respiratory products manufacturer Inhalation Plastics, Inc. and the agency...
You may also be interested in...
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.